Update on Universal Immunization Coverage

1. At a Glance

• U-WIN is the digital backbone of India's Universal Immunization Programme (UIP) — a Co-WIN-modelled portal issuing QR-code vaccination certificates for pregnant women and children up to 16 years. [1][2]
• UIP is the world's largest immunization programme, annually targeting ~2.6 cr children and ~3 cr pregnant women against 12 vaccine-preventable diseases (VPDs). [3]
• High UPSC salience: intersects GS-II (health governance, digital public goods) and GS-III (S&T, public health).

2. Why in the News

• PIB release dated 13 Feb 2026: as on 8 Feb 2026, 11.12 crore children and 3.78 crore pregnant women were registered on U-WIN; 8.01 crore beneficiaries registered during 2025 alone; 29.42 crore SMS reminders sent in 2025. [1]
• U-WIN now integrated with Ayushman Bharat Digital Mission (ABDM), POSHAN Tracker and SAFEVAC. [1]

3. Background & Evolution

• 1978: launched as Expanded Programme on Immunization (EPI). [2][3]
• 1985: rebranded Universal Immunization Programme (UIP) with rural extension. [2][3]
• Dec 2014: Mission Indradhanush (MI) launched to push full immunization to 90%. [3]
• 2017–23: Intensified Mission Indradhanush (IMI) 1.0 → 5.0; IMI 5.0 concluded 14 Oct 2023 with measles–rubella focus. [3]
• 2023: pilot of U-WIN in 65 districts across 36 States/UTs; nationwide rollout thereafter. [2]

4. Core Static Facts

• Implementing Ministry: Ministry of Health & Family Welfare (MoHFW). [1]
• Diseases covered (12 VPDs): Diphtheria, Pertussis, Tetanus, Polio, Measles, Rubella, severe childhood TB, Rotavirus diarrhoea, Hepatitis B, Pneumonia/Meningitis (Hib) nationally + Pneumococcal disease, Japanese Encephalitis (sub-national). [2][3]
• Target cohort on U-WIN: pregnant women + children birth to 16 years. [2]
• Annual scale: ~2.6 cr children + ~3 cr pregnant women under UIP. [3]
• Full immunization coverage: rose from 62% (2015) → 93.5%+ (recent) (NFHS/admin estimates). [3]
• U-WIN model: built on Co-WIN architecture; integrated with ABDM, POSHAN Tracker, SAFEVAC. [1]
• Cost to beneficiary: free of cost. [2]

5. Multi-Dimensional Analysis

Social / Equity

• U-WIN's anywhere-anytime registration tackles migrant and slum drop-outs; QR certificates enable portability across states. [1]
• Targets last-mile gaps that NFHS-5 flagged in tribal & EAG states.

Scientific / Technological

• Indigenous digital public good leveraging the DPI stack (Aadhaar/ABHA + Co-WIN code base). [1]
• Real-time dashboards for due-list generation, AEFI tracking (via SAFEVAC) and cold-chain monitoring.

Administrative / Governance

• Federal split: Centre funds vaccines & cold chain; States deliver via ANMs/ASHAs at ~27,000 cold-chain points.
• Integration with POSHAN Tracker (MoWCD) and ABDM (NHA) breaks ministerial silos. [1]

Economic

• Each ₹1 spent on childhood immunization yields ~₹16 return (WHO global estimate); reduces OOPE on preventable hospitalisation.

Ethical

• Consent-based digital data of minors — raises data-protection (DPDP Act 2023) compliance questions.

6. Recent Developments (last 12-18 months)

• 2025: 8.01 cr beneficiaries registered on U-WIN; 29.42 cr SMS reminders dispatched. [1]
• 8 Feb 2026 snapshot: cumulative 11.12 cr children + 3.78 cr pregnant women registered. [1]
• 2024–25: integration with SAFEVAC (AEFI surveillance), POSHAN Tracker, and ABDM/ABHA. [1]
• Oct 2023: IMI 5.0 concluded with MR focus, aligned to Measles–Rubella elimination 2023 target. [3]

7. Prelims Hooks

• UIP launched 1985 (preceded by EPI, 1978). [2][3]
• Mission Indradhanush launched December 2014. [3]
• UIP currently covers 12 VPDs (10 national + 2 sub-national). [2][3]
• U-WIN target age: birth to 16 years, plus pregnant women. [2]
• U-WIN built on Co-WIN technology architecture. [1]
• U-WIN integrated with ABDM, POSHAN Tracker, SAFEVAC. [1]
• As on 8 Feb 2026: 11.12 cr children, 3.78 cr pregnant women registered. [1]
• 29.42 cr SMSs sent via U-WIN in 2025. [1]
• IMI 5.0 (Aug–Oct 2023) targeted measles & rubella specifically. [3]
• Implementing ministry: MoHFW (not MoWCD; POSHAN Tracker is MoWCD). [1]
• India runs the world's largest immunization programme. [3]
• Pneumococcal Conjugate Vaccine (PCV) made nationwide in UIP in 2021. [2]

8. Mains Relevance

• GS-II: Issues relating to health; Government policies and interventions; e-Governance.
• GS-III: Science & Technology — Digital Public Infrastructure; Achievements of Indians in S&T.
• Probable stems: 1. "Digital Public Infrastructure has redefined the delivery of routine immunization in India. Examine with reference to U-WIN." (GS-II/III) 2. "Mission Indradhanush has substantially reduced the immunization gap but equity challenges persist. Discuss." (GS-II) 3. "Critically evaluate the convergence of U-WIN with ABDM and POSHAN Tracker for outcomes in maternal and child health." (GS-II)

9. Related Topics to Study Next

• Ayushman Bharat Digital Mission (ABDM) — parent digital health backbone.
• POSHAN Abhiyaan & POSHAN Tracker — convergence partner for MCH outcomes.
• NFHS-5 indicators — full immunization, ANC, IMR.
• Mission Indradhanush / IMI 5.0 — campaign cousin of UIP.
• Co-WIN platform — technology precursor to U-WIN.
• Measles–Rubella Elimination target — disease-specific commitment.
• DPDP Act 2023 — implications for paediatric health data.
• GAVI & WHO–SEARO — multilateral immunization partners.

10. Common Errors / Trap Areas

• U-WIN ≠ Co-WIN: U-WIN is for routine immunization; Co-WIN was for COVID-19.
• UIP launched 1985, not 1978 (that was EPI).
• POSHAN Tracker is under MoWCD, not MoHFW — a convergence partner, not parent.
• UIP covers 12 VPDs (not 11 or 13); only 10 nationwide, 2 sub-national.
• Mission Indradhanush launched in 2014 under MoHFW, not under NHM separately.